News
PFE
25.34
+0.52%
0.13
Pfizer, Flagship Pioneerig partner for discovery of novel autoimmune compounds
TipRanks · 3h ago
Trump unlikely to specify any pharma tariffs in ‘Liberation Day’ announcement: Reuters
Seeking Alpha · 4h ago
Pfizer Gets Expanded European Approval of Abrysvo RSV Vaccine for All Adults
Dow Jones · 6h ago
3 Ultra-High-Yield Dividend Stocks to Buy in April
The Motley Fool · 6h ago
Pfizer announces European Commission approval of Abrysvo indication extension
TipRanks · 6h ago
Pfizer: ABRYSVO Now Approved In The EU To Prevent RSV In Adults Aged 18 And Older
NASDAQ · 8h ago
Pfizer's ABRYSVO RSV Vaccine Gains EU Approval For Adults Aged 18-59, Offering Broader Protection Against Lower Respiratory Tract Disease
Benzinga · 8h ago
FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade)
Seeking Alpha · 18h ago
Value Stocks Gain Ground As Inflation, Recession Fears Grow: 4 ETFs To Capitalize On The Trend
Benzinga · 19h ago
Vaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying Opportunity
Seeking Alpha · 20h ago
How Peter Marks' FDA departure is impacting pharma, biotech stocks
Seeking Alpha · 23h ago
Moderna Stock Sinks After Top FDA Official Resigns; Sarepta Gets Hit, Too.
Barron‘s · 1d ago
Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine
Benzinga · 1d ago
Fiery Resignation of Top FDA Official Sparks Biotech Selloff
Barron‘s · 1d ago
Pfizer: Looks Better Than Most, But I Can't Eat Relative Returns
Seeking Alpha · 1d ago
Weekly Report: what happened at PFE last week (0324-0328)?
Weekly Report · 1d ago
Pfizer’s Strong Financial Performance and Strategic Developments Drive Buy Rating
TipRanks · 1d ago
Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors
Seeking Alpha · 2d ago
abrdn Healthcare Investors Q4 2024 Commentary
Seeking Alpha · 2d ago
Hold Rating Maintained for Pfizer Amid Revenue Concerns and Limited Catalysts
TipRanks · 2d ago
More
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
More
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.